Noticias sobre Carlos Fernández de Larrea | Hospital Clínic Barcelona

Clínic Barcelona

Research July 4 2023

The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease

A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1

Clínic Barcelona

Research January 19 2023

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders t1

Clínic Barcelona

Institutional July 22 2022

Representatives of the Spanish Association Against Cancer visit IDIBAPS

The activity, which is part of a new communication project, allowed visitors to learn about the cancer research carried out by the Institute's resear1

Clínic Barcelona

Research December 17 2021

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

Clínic Barcelona

Research November 11 2021

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1

News about Carlos Fernández de Larrea

The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

Representatives of the Spanish Association Against Cancer visit IDIBAPS

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

Subscribe to the Newsletter of Clínic